Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Alyea Clear Patch is an investigational topical pain relief technology developed by Alyea Therapeutics, a subsidiary of ALT 5 Sigma Corporation. Designed for the targeted, localized treatment of chronic and inflammatory pain, the patch provides a non-invasive, non-opioid alternative to traditional analgesics. The technology is characterized by its transparent, water-resistant, and flexible design, allowing for application over joints and other contoured areas of the body with minimal systemic absorption. Originally developed by Soin Bioscience, the patch is intended for both branded prescription and over-the-counter (OTC) markets. As of early 2024, the specific active pharmaceutical ingredient and molecular mechanism of action remain undisclosed, and the product is in the preclinical stage of development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alyea Clear Patch.